Distinguished in Respiratory Acidosis

Stefano Nava

Bologna, IT 
Distinguished in Respiratory Acidosis
Bologna, IT 
OverviewLocationsClinical Research

Overview

Stefano Nava practices in Bologna, Italy. Mr. Nava is rated as a Distinguished expert by MediFind in the treatment of Respiratory Acidosis. His top areas of expertise are Respiratory Acidosis, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), Endoscopy, and Lung Transplant.

His clinical research consists of co-authoring 201 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 11 articles in the study of Respiratory Acidosis.

Gender
Male

Locations

Bologna, Italy
Other Locations
Milan, Italy
Ozzano Dell'emilia, 40064, Italy
Florence, Italy
Sant'orsola, Italy
Alma, Italy
Via G. Sansone 1, Sesto Fiorentino, 50019, Italy
Pavia, Italy
Via G. Sansone 1, Fi, Sesto San Giovanni, 50019, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Completed
Publish Date: October 15, 2025
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3
Effect of Palliative Care in Patients With End Stage Pulmonary Fibrosis: a Randomized Control Pilot Study
Effect of Palliative Care in Patients With End Stage Pulmonary Fibrosis: a Randomized Control Pilot Study
Enrollment Status: Completed
Publish Date: October 28, 2020
Intervention Type: Other
Study Phase: Not Applicable
High Flow Nasal Therapy Versus Noninvasive Ventilation in Mild to Moderate Acute Hypercapnic Respiratory Failure: A Non-inferiority Randomized Trial
High Flow Nasal Therapy Versus Noninvasive Ventilation in Mild to Moderate Acute Hypercapnic Respiratory Failure: A Non-inferiority Randomized Trial
Enrollment Status: Completed
Publish Date: April 30, 2020
Intervention Type: Other
Study Phase: Not Applicable
View 2 Less Clinical Trials

201 Total Publications

Practice of oxygenation and respiratory support during fibreoptic bronchoscopy: the OxyFOB study protocol.
Practice of oxygenation and respiratory support during fibreoptic bronchoscopy: the OxyFOB study protocol.
Journal: BMJ open
Published: September 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Nava's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile